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 ABSTRACT 
 The incidence of clinical mastitis and infection status 
at calving was assessed in quarters treated with 1 of 2 
internal teat sealants at the time of dry off. Two con-
tralateral quarters per cow (n = 63 cows) were treated 
with a sealant that contained 0.5% chlorhexidine; the 
other quarters were treated with a commercial teat 
sealant. Ten cows were untreated (controls). On d 2, 4, 
and 16 after dry off, cows were challenged with Strepto-
coccus uberis S210 strain. Cows were examined daily for 
34 d after drying off and cases of clinical mastitis were 
recorded. Milk samples were collected for culture from 
any quarters that developed clinical mastitis during the 
first 34 d after drying-off and from all quarters on d 
−5 and 0 relative to treatment and at the first and 
twentieth milking after calving. The incidence of clini-
cal mastitis during the examination period was lower 
in treated quarters (n = 7/252; 1.5%; lower incidence 
for those treated with chlorhexidine-containing teat 
sealant n = 3/126; 1.2%) than in untreated quarters 
(n = 13/40; 26.8%). The protection against intramam-
mary infection after calving, adjusted for the effect of 
cow, was higher in quarters treated with the novel teat 
sealant (89/105; 15.2%; 95% CI = 9.6–23.4) than in 
those treated with the commercial teat sealant (71/104; 
31.7%; 95% CI = 23.5–41.3) and untreated controls 
(6/28; 78.6%; 95% CI = 59.8–90.0), respectively. 
Quarters treated with teat sealants were less likely to 
have an intramammary infection after calving and had 
a lower incidence of clinical mastitis during the early 
dry period than did untreated controls in this challenge 
study. 
 Key words:   internal teat sealant ,  challenge ,  dry pe-
riod ,  Streptococcus uberis 
 INTRODUCTION 
 Principles that prevent IMI during the dry period are 
minimizing bacterial challenge from the environment 
and maximizing and supplementing the defense mecha-
nisms of the mammary gland (Bradley and Green, 
2004). Antibiotic dry cow therapy (DCT) is a means of 
preventing new infections during the dry period and of 
eliminating existing subclinical infections. Treatment 
with antimicrobials at drying off risks the development 
of resistant strains of bacteria and violative antibacte-
rial residues in milk after calving. To avoid these risks, 
artificial teat sealants were developed to prevent new 
IMI (Meaney, 1977; Woolford et al., 1998). Teats which 
become closed by the keratin plug or an artificial seal 
after drying off are less likely to become infected in the 
dry period (Woolford et al., 1998; Berry and Hillerton, 
2002; Huxley et al., 2002). The barrier formed by a 
sealant occurs faster than is so without treatment, thus 
decreasing the entry of mastitis-causing organisms into 
the gland while a keratin plug forms. 
 New Zealand’s pasture-based seasonal dairy system 
is associated with some specific problems for the man-
agement of the dry period. The length of the dry period 
is variable and in many cases cows are dried off as dic-
tated by pasture growth and feed availability. The rate 
of new IMI is related to the length of the dry period. 
Longer dry periods have been associated with an in-
crease in the incidence of new IMI (Natzke et al., 1975; 
Rindsig et al., 1978; Bradley and Green, 2004; Berry 
and Hillerton, 2007; Laven, 2008). This may relate to 
the duration of action of the DCT as the concentration 
of antibiotic falls and the protective role against new 
infection challenge is diminished (Bradley and Green, 
2000; Sanford et al., 2006; Berry and Hillerton, 2007). 
The efficacy of internal teat sealants appears unaffected 
by the length of the dry period when used alone or in 
combination with DCT (Woolford et al., 1998; Huxley 
et al., 2002; Berry and Hillerton, 2007). Because the 
prediction of calving date in New Zealand is often not 
reliable and the infection status of cows is unknown, 
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the best mastitis protection is expected from a com-
bined use of DCT and internal teat sealant (Bradley 
and Green, 2004). For known uninfected quarters the 
use of internal teat sealant alone has been advocated 
(Woolford et al., 1998; Bradley and Green, 2004).
The use of internal teat sealants presents the risk of 
introducing new IMI during their administration. This 
risk could potentially be decreased if an antimicrobial 
compound were incorporated into the sealant (Ryan et 
al., 1998; Crispie et al., 2004a) if it possesses a suitable 
spectrum of activity.
This study compared the efficacy of a teat sealant 
containing chlorhexidine with a commercial teat seal-
ant not containing an antimicrobial agent and with un-
treated controls. Treatments were administered at dry-
ing off to healthy dairy cows, which were subsequently 
challenged with a known strain of Streptococcus uberis. 
Chlorhexidine was used because of its activity against 
most gram-positive bacteria of importance in New 
Zealand and other infectious organisms, including some 
gram-negative bacteria when it is at higher concentra-
tions (Heit and Riviere, 2009). The null hypothesis 
tested was that chlorhexidine-containing teat sealant 
would not affect the incidence of clinical mastitis in the 
dry period or the prevalence of IMI after calving.
MATERIALS AND METHODS
This study was approved by the Kaiawhina Animal 
Ethics Committee (AEC 005/09).
Animals
Seventy-three cows less than 8 yr old from Massey 
University Agricultural Farm Services Dairy Number 4 
(Palmerston North, New Zealand) with negative Cali-
fornia Mastitis Test (CMT) and <200,000 cells/mL 9 
d before drying off were used in the present study. The 
experimental unit was the quarter. Sixty-three cows 
were allocated as treatment cows (treated group) and 
10 were untreated controls (untreated group). Treated 
cows had a front and a contralateral rear quarter 
treated with the novel chlorhexidine-containing teat 
sealant and the remaining 2 quarters treated with a 
commercial teat sealant. The treatment was alternated 
between the cows. Cows were randomized on SCC us-
ing the block randomization seed option of GenStat 
software (version 9.1; VSN International, Hemel Hemp-
stead, UK). Five cows failed to complete the study due 
to abortion (1; untreated), traumatic injury resulting 
in death (1; treated), clinical milk fever resulting in 
death (1; treated), and being culled as nonpregnant (2; 
treated) leaving data from 68 cows for analysis of IMI 
status at calving.
Treatment Products and Treatment Administration
Two treatment products were used in this study: 
Bomac ATS, containing bismuth subnitrate 65% and 
chlorhexidine 0.5% (Bomac Laboratories Ltd., Auckland, 
New Zealand), referred to as chlorhexidine-containing 
teat sealant; and Teatseal, containing 65% bismuth sub-
nitrate (Pfizer Animal Health, Auckland) as a positive 
control, referred to as commercial teat sealant.
Treatments were administered within 2 h after the 
last milking for the 2008–2009 season using the par-
tial insertion technique. Before treatment, teats of all 
cows (including untreated controls) were cleaned and 
disinfected with alcohol-based teat wipes (Bomac Teat 
wipes, Bomac Laboratories Ltd.). No massage of the 
teats was performed after treatment administration but 
the teats of all cows (including untreated controls) were 
sprayed with an iodine-based teat spray (TeatGuard 
Plus, Ecolab Ltd., Hamilton, New Zealand) following 
label recommendations.
Procedures
Duplicate quarter milk samples were collected asepti-
cally 5 d before drying off, on the day of drying off and 
at the first and twentieth milking after calving. All milk 
samples were cultured following the National Mastitis 
Council Guidelines (Hogan et al., 1999) at the Microbi-
ology Laboratory of the Institute of Veterinary, Animal 
and Biomedical Sciences (IVABS), Massey University 
(Palmerston North, New Zealand).
All cows were challenged by dipping the teat barrel 
in the challenge broth for 1 to 2 s by a single person 
blinded to treatment. The concentration in the broth of 
colony-forming units of a Strep. uberis S210 strain on d 
2, 4, and 16 after treatment is shown in Table 1. Chal-
lenges were performed in different facilities from the 
normal milking shed to avoid the milk let-down reflex. 
Separate containers were used to dip the left front and 
right rear quarters from those used for the other 2 quar-
ters. In this way, no possibility of cross-contamination 
existed between different products and the blinding of 
the trial was not compromised. Each cow was dipped 
with 2 new challenge broths. A new broth was prepared 
for each day of the challenge.
The challenge broth was prepared by thawing the 
isolate, streaking onto blood agar plates (Fort Richard 
Laboratories Ltd., Auckland, New Zealand), incubation 
at 37 ± 2°C under CO2-enriched conditions, harvest-
ing colonies from the plates using cotton swabs (Fort 
Richard Laboratories Ltd.), and suspending them in 
normal saline (0.9% wt/vol NaCl). The turbidity was 
adjusted to a McFarland turbidity standard of 0.5 (Re-
mel, Lenexa, KS) by adding normal saline.
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Udders were visually examined and palpated daily 
until 34 d after drying off, with the exception of d 1 
and 3, by a person blinded to treatment allocation. 
This was the defined palpation period. Quarters were 
observed and palpated for the presence of clinical signs 
consistent with mastitis. Each quarter was subjectively 
judged as mastitic (score ≥3) or nonmastitic (score 
≤2) according to standardized criteria (Table 2). All 
examinations were performed by a single veterinarian 
blinded to treatment.
Quarters affected by clinical mastitis were sampled 
for microbial culture before treatment was administered 
to them. Microbial culture was performed by spreading 
10 μL of milk from a single quarter onto a quarter of 
a 5% sheep blood agar plate, which was incubated for 
up to 72 h at 35 to 37°C in aerobic conditions (Hogan 
et al., 1999). Any mastitic quarters were then treated 
according to the clinical presentation. For the treat-
ment of affected quarters, Ubro Yellow (Boehringer 
Ingelheim NZ, Auckland, New Zealand; containing pe-
nethamathe hydroiodide, dihydrostreptomycin, framic-
etin, and prednisolone) was administered once daily for 
3 d after complete milking-out of the affected quarters. 
This treatment regimen was used when up to 3 quarters 
in the same cow were affected. When 4 quarters were 
affected in the same cow, Mamyzin (Boehringer Ingel-
heim NZ; containing penethamathe hydroiodide) was 
administered i.m. once daily with 10 g on the first day 
and 5 g on the 2 subsequent days. Thereafter, quarters 
were observed daily and treated as required, but any 
subsequent episode of mastitis in the same quarter was 
not included in the statistical analysis.
The incidence of clinical mastitis during the palpa-
tion period was calculated as the proportion of quarters 
affected by clinical mastitis from the total number of 
quarters in a group. The incidence of clinical mastitis 
caused by the challenge organism during the palpation 
period was calculated as the percentage of quarters af-
fected by clinical mastitis caused by Strep. uberis from 
the total number of quarters in a group. Whenever 
Strep. uberis was isolated, it was assumed it was the 
challenge strain. Previous work by this group using a 
highly discriminative method (pulsed-field gel electro-
phoresis) confirmed that all clinical cases during the 
dry period caused by Strep. uberis were identical to the 
challenge strain (data on file).
Results from culture were assessed according to 
guidelines from the National Mastitis Council (Hogan 
et al., 1999): (a) Growth of 3 or more colony types on a 
quadrant was reported as a contaminated sample, (b) 1 
or 2 colonies growing on the quadrant was reported as 
an uninfected sample, and (c) more than 2 colonies, but 
less than 3 colony types growing on the quadrant was 
reported as an infected sample and the predominant 
colony type was isolated and identified.
Identification of the cultured isolates was performed 
by an assessment of colony morphology, Gram stain re-
action, and several biochemical tests. Bacilli were clas-
sified as gram-positive or gram-negative bacilli, with 
no further testing. Corynebacterium bovis isolates were 
identified based on their cultural characteristics and 
colony morphology. Gram-positive, catalase-positive 
organisms were categorized as either coagulase-positive 
staphylococci or CNS, based on the results of a tube 
rabbit plasma coagulase test (Remel). Gram-positive 
and catalase-negative organisms were further tested for 
their ability to hydrolyze esculin (Fort Dodge, Auck-
land, New Zealand). The esculin-negative organisms 
were subjected to the Christie–Atkins–Munch-Petersen 
(CAMP; Fort Dodge) reaction and categorized as 
either CAMP-positive or CAMP-negative bacteria. 
Nonhemolytic, esculin-positive, gram-positive cocci 
were further tested for their ability to grow in buffered 
azide glucose glycerol broth (BAGG; Fort Dodge) and 
Table 1. The concentration of colony-forming units of a Streptococcs 
uberis S210 strain per milliliter in the challenge broth at different 
challenge days 
After 
treatment  
(d)
Concentration  
(cfu/mL)
2 7.7 × 108
4 5.4 × 107
16 2.3 × 107
Table 2. Quarter and teat examination scores and description 
Score Description
0 No evidence of irritation, soreness, redness, or swelling of the quarter. No stripping of quarters.
1 No or virtually no evidence of irritation, soreness, redness, or very slight swelling of the quarter. No stripping of quarters.
2 Evidence of irritation or soreness of a minor intensity or slight redness or swelling, likely 
to originate from residual milk in the quarter. No stripping of quarters.
3 Evidence of irritation or soreness of a moderate intensity or moderate redness or 
swelling of the quarter. Secretion contains small clots and flecks.
4 Evidence of irritation or soreness of a severe intensity or severe redness (beet redness) or 
severe swelling of the quarter. The secretion contains large clots and flecks.
5 Evidence of severe irritation or soreness, severe swelling or redness, associated with a 
generally sick animal. The secretion contains large clots and flecks.
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fermented inulin (Fort Dodge). The BAGG-positive 
inulin fermenters were identified as Strep. uberis. All 
of the other gram-positive, catalase-negative cocci were 
identified as Streptococcus spp.
The presence of an IMI in any quarter after calving 
was determined based on an assessment of the culture 
results. A gland was defined as being infected if growth 
of ≥3 colony forming units per quadrant of any of 
the major mastitis-causing organisms (i.e. coagulase-
positive staphylococci, streptococci, and gram-negative 
rods) was present at a sampling and if a minor or 
uncommon or any combination of mastitis-causing or-
ganisms was isolated at both samplings after calving. 
The prevalence of infection after calving was evaluated 
independently of the infection status pre-drying off 
and the incidence of clinical mastitis during the palpa-
tion period. Any quarters with contaminated samples 
or missing samples after calving were excluded from 
analysis unless they were a sample containing a major 
mastitis-causing organism.
Statistical Analysis
All analyses were undertaken using SAS version 9.1 
(SAS Institute, 2003).
Statistical differences between the cumulative per-
centages of quarters becoming infected in the treatment 
groups (chlorhexidine-containing teat sealant, commer-
cial teat sealant, and untreated controls) were analyzed 
using survival analysis using the SAS LIFETEST pro-
cedure.
Udder palpation scores for each quarter were ana-
lyzed as categorical data using the Fisher exact test 
with respect to treatment (chlorhexidine-containing 
teat sealant, commercial teat sealant, and untreated 
controls).
Records of clinical mastitis for each quarter dur-
ing the 34-d palpation period were analyzed using 
the SAS GLIMMIX procedure with a logistic regres-
sion model that included the fixed effect of treatment 
(chlorhexidine-containing teat sealant, commercial teat 
sealant, and untreated controls) and the random effect 
of a cow. The variable had a binomial distribution and 
analyses were performed after the logit-transformation. 
Least squares means of incidence of clinical mastitis 
and their 95% confidence intervals were obtained and 
back-transformed to the binomial scale. The same pro-
cedure was applied to compare the incidence of clinical 
mastitis in the treated versus untreated quarters during 
the palpation period.
The success in preventing IMI measured as presence 
or absence of infection after calving was analyzed with 
the GLIMMIX procedure. The logistic regression model 
included the fixed effect of treatment (chlorhexidine-
containing teat sealant, commercial teat sealant, and 
untreated controls) and random effect of a cow. Least 
squares means and 95% confidence intervals for IMI 
after calving for each treatment were back-transformed 
and are presented as means and 95% confidence in-
tervals. The effect of the length of the dry period on 
the success of the prevention of IMI after calving was 
not significant (Table 3). Hence, it was not included 
in the final model for estimation of the success of the 
prevention of IMI after calving. The prevalence of in-
fected (positive on culture) quarters per group was also 
analyzed using the GLIMMIX procedure, including 
the fixed effects of treatment (chlorhexidine-containing 
teat sealant, commercial teat sealant, and untreated 
controls), sampling point, and their interaction. Least 
squares means and standard errors of the prevalence of 
infected or noninfected quarters at each sampling point 
were back-transformed and are presented as means and 
their standard errors. The prevalence of contaminated 
quarters was not different between the groups and they 
were excluded from the analysis.
The least squares means of lengths of dry periods 
and their 95% confidence intervals and differences for 
the treatment groups were estimated using the SAS 
MIXED procedure with a linear model that included 
the fixed effect of treatment (chlorhexidine-containing 
teat sealant, commercial teat sealant, and untreated 
controls).
RESULTS
Dry Period
The lengths of the dry periods were similar between 
the treated (103.1 d; 95% CI = 98.0–108.3) and un-
treated (96.1 d; 95% CI = 83.0–109.3; P = 0.334) cows.
Udder Palpation Scores
Palpation results were available for all 73 cows (Table 
4) for the 34 d after drying off, with the exception of 1 
cow from the untreated control group that had udder 
palpation performed until d 17; then the cow aborted 
and was excluded from the study. Four further cows (all 
treated) missed palpations on a total of 6 occasions. 
The effect of treatment on the frequency of palpation 
scores was significant (P < 0.001).
The frequency of palpation scores ≥3 was highest on 
d 10, 16, and 19 for the chlorhexidine-containing teat 
sealant-treated quarters and on d 6, 16, and 19 for com-
mercial teat sealant-treated quarters (maximum value 
of 3/126 quarters on d 19). The frequency of palpation 
scores ≥3 in untreated quarters was highest on d 9, 10, 
and 14 (4/40 quarters on each occasion).
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Clinical Mastitis During the Palpation Period
During the palpation period, 20 quarters from 9 cows 
developed clinical mastitis. Fourteen of these mastitis 
cases were caused by Strep. uberis (Table 5). Quarters 
treated with chlorhexidine-containing teat sealant had 
1.2% infected (95% CI = 0.3–5.4) versus 26.8% in un-
treated quarters (95% CI 7.6–62.0; P < 0.001).
The highest risk for the incidence of clinical mastitis 
during the palpation period was between 6 and 19 d 
after drying off (Figure 1).
Milk Culture Results
Thirteen contaminated samples, and 13 and 5 missing 
samples from the chlorhexidine-containing commercial 
teat sealant and untreated controls, respectively, were 
not available for analysis. The culture results are pre-
sented in Table 6. The distribution of mastitis-causing 
organisms was similar in the groups before drying off, 
but differences were evident after calving. A higher 
prevalence of major mastitis-causing organisms was 
detected in the untreated quarters and quarters treated 
with the commercial teat sealant compared with quar-
ters treated with the chlorhexidine-containing teat 
sealant. This was largely an effect of coagulase-positive 
staphylococci rather than the challenge organism. The 
prevalence of minor mastitis-causing organisms was 
2.5 and 16.9% at the first milking and 10.2 and 13.6% 
at the twentieth milking in quarters treated with the 
chlorhexidine-containing teat sealant and those treated 
with the commercial teat sealant, respectively. Quarters 
affected by clinical mastitis in the first 34 d after dry-
ing off were treated at the time of diagnosis and signs 
of clinical mastitis subsided. Despite this, Strep. uberis 
was isolated from 7 quarters after calving: 5 from the 
untreated group and 1 of each treated with commercial 
or chlorhexidine-containing teat sealant.
The prevalence of IMI after calving was significantly 
different between the groups (Table 7). It was highest 
in untreated quarters, followed by quarters treated with 
the commercial teat sealant. The lowest prevalence 
of IMI after calving was in quarters treated with the 
chlorhexidine-containing teat sealant.
DISCUSSION
This study demonstrates that administration of 
an internal teat sealant containing chlorhexidine at 
the last milking of the lactation resulted in the low-
est prevalence of IMI with any pathogen observed at 
calving compared with treatment with a conventional 
teat sealant or no treatment. The incidence of clinical 
mastitis during the first 34 d of the dry period was Ta
b
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significantly lower in quarters treated with chlorhexi-
dine-containing or the commercial teat sealant than in 
untreated quarters. The incidence of clinical mastitis 
caused by the challenge organism during this period 
was not significantly different between groups treated 
with either teat sealant but was significantly lower in 
them than in the untreated group. The lower preva-
lence of IMI after calving in the quarters treated with 
the chlorhexidine-containing teat sealant should result 
in a lower prevalence of mastitis throughout lactation, 
as noninfected cows at calving are less likely to develop 
mastitis (Barkema et al., 1998; Woolford et al., 1998). 
The modest decrease of IMI after calving was because 
of bacteria different from the challenge organisms. This 
suggests that the risk of infection by other organisms 
was decreased. However, as the prevalence of other or-
ganisms was not a subject of interest, this en passent 
observation is not a definite conclusion.
It would be expected that microbial challenge under 
natural conditions would be less intense than that in 
the present study. The challenge broth contained a 
concentration of bacteria that would not be expected 
to occur under natural conditions. Moreover, quarters 
were exposed to challenge with a single strain of Strep. 
uberis. This differs from the situation in natural condi-
tions, in which animals would be expected to encounter 
a diverse microbial challenging flora. Despite these 
caveats, the challenge model used in the present study 
was valid, because both the model and the strain used 
for the present study have been used previously with 
success. This model was shown to be highly effective 
in causing IMI in untreated quarters in the early dry 
period (Fernandez, 2007; K. Petrovski, N. B. William-
son, A. Grinberg, N. Lopez-Villalobos, T. J. Parkinson, 
and I. G. Tucker, unpublished data). Hence, the results 
are applicable to the external population. Only cows 
with <200,000 somatic cells/mL and no history of clini-
cal mastitis in the previous lactation were included in 
the present study. Cows from a single farm were used 
in the current study to prevent inter-farm variability 
(Barkema et al., 1999; Godden et al., 2003; Newton et 
al., 2008). As the effect of the individual cow on the 
results of challenge experiments is generally significant 
(Huxley et al., 2002; Newton et al., 2008), this was 
included in the modeling. The split study design, in 
which 2 quarters per cow were treated with the novel 
sealant and the other 2 quarters with a conventional 
sealant, which was used in the present study may actu-
ally underestimate the true efficacy of the prevention 
capabilities of the test items at the cow level (Berry et 
al., 2003). Regardless, any such effect would affect both 
products used in the study equally and not bias the 
results toward either of the treatments.
The number of cows in the present study was ad-
equate to allow rejection of the null hypothesis (power 
analysis not shown). Although relatively few cows were 
enrolled in the negative control group, this approach 
was taken to limit the unnecessary suffering of animals, 
given that the challenge procedure is highly effective. 
The treated and untreated groups had similar infec-
tion status before drying off, as only 2 glands (1 in the 
chlorhexidine-containing teat sealant-treated and 1 in 
Table 4. Effect of treatment on palpation scores in the first 34 d after drying off 
Score
Chlorhexidine-containing 
teat sealant Commercial teat sealant Untreated Total
n % n % n % n %
0 3,930 92 3,898 91.3 1,078 83.4 8,906 90.5
1 291 6.8 299 7 137 10.6 727 7.4
2 48 1.1 70 1.6 58 4.5 176 1.8
3 3 0.1 5 0.1 15 1.2 23 0.2
4 0 0 0 0 4 0.3 4 0
5 0 0 0 0 0 0 0 0
Table 5. Distribution of cases of clinical mastitis (CM), the probability of a quarter being affected by CM (probability total), and the 
probability of a quarter of being affected with CM caused by the challenge organism (probability challenge) in the first 34 d after drying off 
Group
Treatment  
group
Quarters affected  
by CM
Quarters with  
positive isolation
Probability total  
(% and 95% CI)
Probability challenge  
(% and 95% CI)n % n %
1 Chlorhexidine-containing teat sealant 3 2.4 1 0.8 1.2 (0.3–5.4) 0.7 (0.1–5.1)
1 Commercial teat sealant 4 3.2 1 0.8 1.8 (0.5–6.6) 0.7 (0.1–5.1)
2 Untreated 13 32.5 12 30.0 26.8 (7.6–62.0) 25.3 (8.6–55.0)
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the untreated group) were infected with a major patho-
gen at drying off (Table 6). The study design did not al-
low for detailed analysis of microbial results and, hence, 
no lengthy discussion on this will be attempted. The 
overall effect of treatment on the prevalence of IMI was 
significant. The study did not attempt to estimate the 
effect of the teat sealants on existing IMI. As chlorhexi-
dine was incorporated in the novel teat sealant solely 
for its local activity in the teat canal and teat cistern, 
it was assumed that cows with pre-existing infection 
that cured did so as a result of self-cure rather than 
the effect of the introduced chlorhexidine in the teat 
sealant. This could be the subject of further research. 
Additionally, the lengths of the dry periods were also 
similar (103 and 96 d for the treated and untreated 
cows, respectively). Hence, differences in the length 
of the dry period cannot explain the observed differ-
ences in quarter IMI at calving. Regardless, a higher 
probability of infection at calving would be expected 
in treated quarters because of their longer dry period 
(Rindsig et al., 1978; Berry and Hillerton, 2007).
Six quarters that developed clinical mastitis dur-
ing the first 34 d after treatment and were treated for 
clinical mastitis according to the study protocol yielded 
Strep. uberis after calving. Previous work by this group 
has confirmed by pulsed-field gel electrophoresis that 
all clinical cases during the dry period and most sub-
clinical infections after calving were caused by Strep. 
uberis identical to the challenge strain (data on file). 
The in vitro tests performed on the challenge strain 
have shown a high susceptibility to all β-lactam anti-
biotics. The reason for the finding of these infections 
after calving is not clear. They may have resulted from 
treatment failure or reinfection.
Since their development in the 1970s, internal teat 
sealants containing bismuth subnitrate have been evalu-
ated in Canada, Ireland, New Zealand, the United King-
dom, and the United States. Studies have demonstrated 
that application of teat sealant to uninfected mammary 
glands is at least as effective as a long-acting DCT, if 
not better, in decreasing the rate of new IMI during the 
dry period (Meaney, 1977; Woolford et al., 1998; Berry 
and Hillerton, 2002; Godden et al., 2003; Crispie et al., 
2004a,b; Cook et al., 2005). The chlorhexidine-contain-
ing teat sealant used in the present study demonstrated 
superior protection to that of the conventional teat 
sealant when measured as the prevalence of IMI with 
all pathogens after calving. The reason for this benefit, 
compared with the lack of advantage of combining teat 
sealant and DCT (Woolford et al., 1998), is not clear. 
However, it appears to support the hypothesis of the 
study; namely, that it is a result of the local activity of 
chlorhexidine destroying organisms in the teat cavity, 
either those which invaded before the sealant formed Ta
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a perfect plug or those introduced with the treatment. 
On the other hand, antimicrobial concentration from 
the DCT around the time of calving may be lower than 
the minimal inhibitory concentrations, leading to in-
creased susceptibility to new infections. Moreover, the 
teat sealants form a persistent barrier, which, in the 
case of the chlorhexidine-containing teat sealant may 
protect against organisms invading teats that have the 
sealant plug loosened from the teat cistern wall, such 
as leaky teats.
Currently, available teat sealants are not ideal for 
preventing new IMI during the dry period, inasmuch 
as a failure to protect 2.0 to 42.5% of quarters has 
been reported (Woolford et al., 1998; Huxley et al., 
2002; Bradley et al., 2010). The most likely reason for a 
failure of prevention could be the risk of contaminating 
quarters during treatment, because conventional teat 
sealants lack constituents with antimicrobial properties 
(Bradley and Green, 2004). Aseptic technique during 
administration is paramount for the infusion of any 
intramammary product, but it is known that farming 
practice varies widely, possibly based on the assump-
tion that it is less important when infusing antimicro-
bial formulations (Woolford et al., 1998). Prophylactic 
administration of DCT to uninfected quarters could 
predispose cows to new IMI because of disruption of 
the epithelial integrity of the teat canal; accidental in-
troduction of mastitis-causing organisms from around 
the teat end, particularly when they are resistant to 
the antimicrobial used; or disruption of the normal 
microflora (Williamson et al., 1995; Huxley and Brad-
ley, 2002; Godden et al., 2003; Crispie et al., 2004b). 
The effect of new IMI introduced by this procedure is 
difficult to quantify: they may persist until the next 
lactation but also could result in acute onset of clini-
cal mastitis before the active involution of the gland is 
finished (Smith et al., 1985; Bradley and Green, 2004). 
The coagulase-positive staphylococci present at calving 
and absent at drying off in quarters treated with com-
mercial teat sealant may have been introduced during 
treatment or have invaded the teat canal in the early 
dry period from micro skin lesions surrounding the teat 
canal. This is supported by the lower prevalence of mi-
nor mastitis-causing organisms in quarters treated with 
Table 7. Means and 95% confidence intervals of the quarter level infection rate after calving 
Treatment Mean
95%  
CI
Difference from  
chlorhexidine-containing  
teat sealant
Chlorhexidine-containing teat sealant 15.24 9.55–23.44 NA
Commercial teat sealant 31.73 23.52–41.26 0.009
Untreated 78.57 59.79–90.04 0.002
Figure 1. Survival analysis from treatment to incidence of clinical mastitis (chlorhexidine-containing teat sealant − · −, commercial teat 
sealant _____, untreated − − −) during the first 34 d after drying-off.
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chlorhexidine-containing teat sealant when compared 
with quarters treated with commercial teat sealant and 
untreated quarters (Table 6). Therefore, to overcome 
this shortcoming of currently-available teat sealants, 
the addition of an appropriate antimicrobial agent, 
such as in the novel internal teat sealant, appears to 
be a worthwhile approach. The confidence of farmers in 
sealant may increase with the presence of antimicrobial 
compounds in the formulations. The sealant provides a 
barrier throughout the dry period against many micro-
bial species that gain entry into the gland through the 
teat canal. Furthermore, an effective antimicrobial will 
inhibit or kill mastitis-causing organisms that evade 
the teat sealant plug (Ryan et al., 1998; Godden et 
al., 2003). This possibly explains the observed lower 
number of infected quarters at calving that was found 
in the present study in quarters treated with the novel 
internal teat sealant when compared with untreated 
quarters and those treated with the commercial teat 
sealant. The results support a view that chlorhexidine-
containing teat sealant decreased the ability of major 
and minor mastitis-causing organisms to penetrate the 
teat canal and establish IMI during the dry period.
CONCLUSIONS
This study demonstrates positive effects from the use 
of an existing and a novel internal teat sealant con-
taining chlorhexidine in cows with low SCC and no 
history of clinical mastitis during the previous lactation 
on the prevalence of new IMI after calving and on the 
incidence of clinical mastitis in the nonlactating period.
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